John Bartholomew, MD is Section Head of Vascular Medicine and a staff physician in the Sydell and Arnold Miller Family Heart & Vascular Institute. He has a joint appointment to the Department of Hematology/Oncology. He is board-certified as a Diplomat of the American Board of Internal Medicine and the American Board of Vascular Medicine. He is a Professor of Medicine for the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Bartholomew's specialty interests include clotting disorders (acquired and inherited), such as heparin-induced thrombocytopenia, antiphospholipid syndrome, thrombosis in cancer patients, protein C and S deficiencies, antithrombin deficiency and prothrombin gene mutation and Factor V Leiden, as well as elevated Factor VIII and homocysteine levels. In addition, Dr. Bartholomew's other clinical interests include peripheral arterial disease, the swollen limb including lymphedema, lipedema, thromboembolism (deep vein thrombosis and pulmonary embolism), and leg ulcers.
Dr. Bartholomew is the Medical Director of the Pharmacy managed Anticoagulation program, as well as Director of the Vascular Medicine Section’s Coumadin Clinic. In 2003, Dr. Bartholomew was part of the clinical faculty for the Joint Commission Resources, Inc., for the Joint Commission on Accreditation of Hospital Organizations (JCAHO). He has also been a member of the Deep Vein Thrombosis Steering Committee for the National Quality Forum, which sets the national standards for the care of patients with Deep Vein Thrombosis and Pulmonary Embolism. He currently serves as the Director of the Cleveland Clinic Health Systems efforts to prevent and treat deep vein thrombosis and pulmonary embolism.
Dr. Bartholomew was voted one of Cleveland's Best Doctor's by Cleveland Magazine from 2006 through 2011 and in 2004, 2002, 2001 and 1998. In 2001, he was named Teacher of the Year by Cleveland Clinic’s Department of Vascular Medicine.
He has published numerous articles and abstracts in professional scientific journals including the Annals of Internal Medicine, Transfusion, Cardiovascular Surgery, Circulation, the Cleveland Clinic Journal of Medicine, Chest, Archives of Internal Medicine, Journal of Pediatrics, and Vascular Medicine on topics related to smokeless tobacco and cardiovascular risk, peripheral artery disease, pulmonary embolism, and heparin-induced thrombocytopenia and deep vein thrombosis, among others. He has authored more than 50 book chapters in medical textbooks related to atheromatous embolization, stasis leg ulcers, hypercoagulable states, heparin-induced thrombocytopenia, and peripheral arterial disease.
He is a fellow of the Society for Vascular Medicine, a fellow of the American College of Cardiology, a fellow of the International Academy of Clinical and Applied Thrombosis and Hemostasis. He is a member of the American College of Physicians, the Johns Hopkins Medical and Surgical Society, the American Society of Hematology and the International Society of Thrombosis and Hemostasis.